{"product_id":"global-osteoarthritis-gene-therapy-market-growth-status-and-outlook-2023-2029","title":"Global Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Osteoarthritis Gene Therapy Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Osteoarthritis Gene Therapy Industry Forecast” looks at past sales and reviews total world Osteoarthritis Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Gene Therapy sales for 2023 through 2029. With Osteoarthritis Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Gene Therapy industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Osteoarthritis Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoarthritis Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Gene Therapy market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Gene Therapy.\u003c\/p\u003e\n\n\u003cp\u003eThe global Osteoarthritis Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eUnited States market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eChina market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eEurope market for Osteoarthritis Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key Osteoarthritis Gene Therapy players cover Flexion, GeneQuine, Novartis, Smith \u0026amp; Nephew, Genascence, Kolon TissueGene, Sanofi, Paraxel and Medipost, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Gene Therapy market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nSynovium Injection\u003cbr\u003e\nCartilage Injection\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nHospitals and clinics\u003cbr\u003e\nOrthopedic Centers\u003cbr\u003e\nAssisted living Facilities\u003cbr\u003e\nNursing Homes\u003cbr\u003e\nAmbulatory Surgical Centers\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nFlexion\u003cbr\u003e\nGeneQuine\u003cbr\u003e\nNovartis\u003cbr\u003e\nSmith \u0026amp; Nephew\u003cbr\u003e\nGenascence\u003cbr\u003e\nKolon TissueGene\u003cbr\u003e\nSanofi\u003cbr\u003e\nParaxel\u003cbr\u003e\nMedipost\u003cbr\u003e\nMundipharma\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 100 Pages \/ MCW16226976","offer_id":47645902897458,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-osteoarthritis-gene-therapy-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}